Advertisement
News
Subscribe to MDT Magazine News

Leading Hong Kong Hospital Is Recipient and First to Order Two TomoHD(R) Treatment Systems Worldwide

February 17, 2011 11:45 am | by The Associated Press | Comments

http://www.tomotherapy.com () —TomoTherapy Incorporated (http://www.tomotherapy.com/) (NASDAQ: TOMO), maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that it has shipped its 350th treatment system. The milestone unit is the first...

SME Honors Loyal Member with the 2011 Award of Merit

February 17, 2011 11:36 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., February 17, 2011 — The Society of Manufacturing Engineers (SME) announced today that it is recognizing Robert V. Petrach Jr., CMfgE, with the 2011 Award of Merit, for the contributions he has made to the his local chapter, affiliated chapters and the Society...

Drug Follows Melanoma Wherever It Goes

February 17, 2011 11:36 am | by Massachusetts Institute of Technology | Comments

Researchers are testing the safety of a nanoparticle that targets cancer cells.

Advertisement

Important Information: Additional Recalled Lubricating Jelly Products

February 17, 2011 10:45 am | by The Associated Press | Comments

Following our communication (http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2011/2011_06-eng.php) regarding Bowers Medical Ltd. voluntary recall of Triad Group's sterile lubricating jelly, Health Canada is informing Canadians that additional health products have been identified....

Brupbacher Prize goes to B. Vogelstein and J. Hoeijmakers for research on colorectal and skin cancer

February 17, 2011 10:34 am | by EurekAlert | Comments

(University of Zurich) Today, the Charles Rodolphe Brupbacher Prize for Cancer Research 2011 goes to two researchers who have contributed to better understanding of the genetics underlying the growth of tumors. Oncologist Bert Vogelstein has demonstrated how sequential accumulation...

TOPICS:

Warfarin Sodium Tablets (Jantoven), 3mg: Recall - Mislabeled Bottles Containing Higher Dosage

February 17, 2011 10:33 am | by U.S. Food & Drug Administration | Comments

10mg strength tablets found in bottle labeled as 3 mg.

Intrinsic Enrolls First Patient in Barricaid® Trial

February 17, 2011 10:32 am | by Bio-Medicine.Org | Comments

WOBURN, Mass., Feb. 17, 2011 /- Intrinsic Therapeutics, Inc., a developer of novel lumbar spine anulus closure devices, announced today that it has enrolled the first patient, December 17, 2010, in a Randomized Clinical Trial of its Barricaid® device. Barricaid is designed to prevent...

TOPICS:

Success Factors and Failure Points in Biopharmaceutical Product Launches

February 17, 2011 9:36 am | by Bio-Medicine.Org | Comments

CHAPEL HILL, N.C., Feb. 17, 2011 /- Recent biopharmaceutical product launches have produced both noteworthy failures and successes. Faced with a continually evolving launch landscape, organizations are rethinking the factors that play the biggest role in the current launch environment. In...

TOPICS:
Advertisement

FDA Warns Against Certain Uses of Asthma Drug Terbutaline for Preterm Labor

February 17, 2011 9:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Feb. 17, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning that terbutaline administered by injection or through an infusion pump should not be used in pregnant women for prevention or prolonged (beyond 48-72 hours) treatment of preterm...

TOPICS:

New Clinical Study Shows RyMed InVision-Plus® IV Connector Dramatically Reduced Catheter-Related Bloodstream Infections by Over 92%

February 17, 2011 9:35 am | by Bio-Medicine.Org | Comments

FRANKLIN, Tenn., Feb. 17, 2011 /- Georgia Health Sciences University, Augusta, GA  exhibited a poster at the recent 11th National Conference on Cancer Nursing Research in Los Angeles, in which their clinical study showed RyMed Technologies ' zero displacement InVision-Plus® IV...

TOPICS:

Radiologic Associates of Fredericksburg Announces Image Gently Campaign to 'Child Size' Doses for Children

February 17, 2011 9:33 am | by Bio-Medicine.Org | Comments

FREDERICKSBURG, Va., Feb. 17, 2011 /- Radiologic Associates of Fredericksburg (RAF) has partnered with the Image Gently Campaign to increase awareness of opportunities to lower radiation dose when imaging children.  Image Gently is an initiative of the Alliance for Radiation Safety...

TOPICS:

Correction: Cell Therapeutics story

February 17, 2011 8:45 am | by The Associated Press | Comments

In a story Feb. 16 about Cell Therapeutics Inc., The Associated Press reported erroneously the status of a clinical trial of the company's drug candidate Pixuvir. Cell Therapeutics will start a new trial during the first quarter even if the drug developer's appeal of a previous regulatory...

Healthy lifestyle, positive attitude can help improve patient outcomes

February 17, 2011 8:37 am | by EurekAlert | Comments

(American Academy of Orthopaedic Surgeons) Joint replacement patients who improve their lifestyle and maintain a positive mindset prior to surgery are more likely to have better functional outcomes than those who do not, according to research presented today at the 2011 Annual...

TOPICS:

ICAP Ocean Tomo Announces Advanced Techniques for Measuring Blood Pressure From Coherence L.L.C.

February 17, 2011 8:34 am | by Bio-Medicine.Org | Comments

CHICAGO, Feb. 17, 2011 /- The method represented in the Coherence L.L.C. patent integrates the measurement of a respiratory arterial pressure wave (a blood wave that rises and falls with exhalation and inhalation) into conventional blood pressure readings to provide healthcare...

TOPICS:

Terbutaline: Label Change - Warnings Against Use for Treatment of Preterm Labor

February 17, 2011 8:31 am | by U.S. Food & Drug Administration | Comments

Potential for serious maternal heart problems and death.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading